4//SEC Filing
Friedman Franklin Stuart 4
Accession 0001209191-23-004002
CIK 0001654151other
Filed
Jan 18, 7:00 PM ET
Accepted
Jan 19, 4:06 PM ET
Size
5.7 KB
Accession
0001209191-23-004002
Insider Transaction Report
Form 4
Friedman Franklin Stuart
Director
Transactions
- Award
Stock Option (Right to Buy)
2023-01-17$15.30/sh+3,269$50,000→ 3,269 totalExercise: $21.27Exp: 2033-01-16→ Common Stock (3,269 underlying)
Footnotes (1)
- [F1]These options were issued upon election by the director to receive his cash board retainer fee of $50,000 for the FY 2023 in the form of an equity award, in lieu of cash, under the amended and restated non-employee director compensation policy. The shares will vest in four substantially equal installments on each of March 31, 2023, June 30, 2023, September 30, 2023 and December 31, 2023.
Documents
Issuer
Deciphera Pharmaceuticals, Inc.
CIK 0001654151
Entity typeother
Related Parties
1- filerCIK 0001794351
Filing Metadata
- Form type
- 4
- Filed
- Jan 18, 7:00 PM ET
- Accepted
- Jan 19, 4:06 PM ET
- Size
- 5.7 KB